60 DEGREES PHARMACEUTICALS, INC.: cashflow_financing
| Value | {"amount": 6437691, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} |
|---|---|
| Period | 2025-01-01 – 2025-12-31 |
| Status | current |
| Entity | 60 DEGREES PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:58:51.297335+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/cf227161-3fb5-41e7-b301-fa4f7d60f3d0
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001554855-26-000467Retrieved: 2026-08-19T18:58:51.297335+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001946563/cashflow-financing/2025-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/cf227161-3fb5-41e7-b301-fa4f7d60f3d0
History
- no predecessors — first report